Geisinger becomes first in U.S. to treat cancer patients with Accuray Synchrony® technology on the Radixact® and CyberKnife® S7™ Systems to better target radiation treatments
- Monday, May 3, 2021, 6:51
- PR Newswire
- Add a comment
WILKES-BARRE, Pa. and SUNNYVALE, Calif., May 3, 2021 /PRNewswire/ — Geisinger continues to bring advanced cancer care closer to home as it is the first hospital system in the U.S. to offer Accuray Incorporated’s (NASDAQ: ARAY) newest Synchrony® technology on both the CyberKnife® S7™ and…
About the Author
admin has written 21636 stories on this site.